Reduce late-stage attrition with AI-powered safety assessment. ICH-aligned, NAMs-ready, delivered in weeks not months. 37+ production modules. Peer-reviewed at AAAI, NeurIPS, Stanford.
Full nonclinical pharmacology & toxicology dossier powered by AI. Three integrated engines assess toxicity, allergenicity, and mutation impact — delivering regulatory-ready reports in weeks.
| Endpoint | Prediction | Score | Verdict |
|---|---|---|---|
| hERG Inhibition | Non-blocker | 0.92 | SAFE |
| AMES Mutagenicity | Non-mutagen | 0.97 | SAFE |
| DILI Risk | Low risk | 0.89 | SAFE |
| CYP3A4 Inhibition | Moderate | 0.54 | MONITOR |
| Skin Sensitization | Non-sensitizer | 0.91 | SAFE |
| BBB Penetration | Moderate | 0.62 | MONITOR |
Submit your target or compound. Our AI pipeline screens, docks, simulates, and verifies — delivering a regulatory-ready report with forensic-grade integrity.
Complete computational drug discovery stack. Each module is production-tested, forensically verified, and ready for regulatory submission.
No surprise fees. No platform licenses. Pay for the analysis you need, when you need it.
Get a free sample toxicology assessment for your compound. See the quality of our reports before you commit.